APA (7th ed.) Citation

T, V., L, K., V, D., W, T., J, C., S, M., . . . I, S. (2004). Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet, 363(9421), 1607. https://doi.org/10.1016/s0140-6736(04)16205-3

Chicago Style (17th ed.) Citation

T, Vollmer, Key L, Durkalski V, Tyor W, Corboy J, Markovic-Plese S, Preiningerova J, Rizzo M, and Singh I. "Oral Simvastatin Treatment in Relapsing-remitting Multiple Sclerosis." Lancet 363, no. 9421 (2004): 1607. https://doi.org/10.1016/s0140-6736(04)16205-3.

MLA (9th ed.) Citation

T, Vollmer, et al. "Oral Simvastatin Treatment in Relapsing-remitting Multiple Sclerosis." Lancet, vol. 363, no. 9421, 2004, p. 1607, https://doi.org/10.1016/s0140-6736(04)16205-3.